← All trials
NCT06581406
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 27, 2025
- Primary completion
- Jan 31, 2030
- Completion date
- Oct 31, 2031
- First posted
- Sep 3, 2024
- Last posted
- Nov 8, 2024
- Enrollment
- 280
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Replimune Inc.Lead sponsor
- Replimune Inc.Official
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.